Pharma Liability Shields Could Be at Risk if Fraud is Found, says Former Blackrock Investment Executive
Dowd says that big pharma is supposed to be one of the most regulated industries, particularly with the Food and drug administration (FDA) however, after touting that the jabs are safe and also effective, their blanket immunity from liability may no longer apply if fraud is found to have occurred.
This could be game over for companies such as Moderna and other mRNA manufacturers, as big insurance is prepping to “square off” with big pharma over life insurance pay-outs linked to the COVID gene therapy jab, according to the Equity Investment Executive Edward Dowd.
Pfizer received blanket immunity from liability through the EUA, however, it is looking like this product is deadly according to Dowd, yet it is others who are being financially burdened.
Former Blackrock exec believes liability shields could be at risk if fraud is found
“Fraud eviscerates all contracts” 👀
Full Interview: https://t.co/qV7LdElPZw pic.twitter.com/KxL0YALQTr
— Chief Nerd (@TheChiefNerd) January 31, 2022
We are seeing many incidences of deaths and disabilities from these vaccines from the adverse events databases such as VAERs, but according to Dowd, “now the actuarial insurance companies are seeing in their results”.
Aegon insurance in their third-quarter results in their U.S unit saw an increase in death claims from 31 million in 2020 to 111 million in 2021, that’s an increase of approximately 268 percent and according to Dowd, “It is not just a medical scam it is a financial and capital market scam.”
On August 23, 2021, the Food and Drug Administration (“FDA”) approved the PfizerBioNTech COVID-19 Vaccine, for individuals 16 years of age and older. Four days later, a Freedom of Information Act Request was submitted.
The FDA asserted that the Pfizer product “meets the high standards for safety, effectiveness, and manufacturing quality”, although, numerous public health officials, media outlets, journalists, scientists, politicians, public figures have publicly raised questions regarding the sufficiency of the data and information, the adequacy of the review, and the appropriateness of the analyses relied upon by the FDA to license the Pfizer Vaccine (source).
Nevertheless, despite their commitment to ”transparency”, It appears that the FDA has been reluctant to share the necessary data and even attempted to challenge the FOIA in court, with a request to release 500 pages a month, which allow all files to be accessed around 2076.
This, it could be argued, is a tad suspicious as the FDA themselves were able to deem the gene therapy jab worthy of an Emergency Use Authorisation after only 108 days of sifting through Pfizer data (source).
FOIA Compliance Was Ordered
Nonetheless, even within the first batch released we could see that both Pfizer and the FDA knew that the jab was anything but “safe and effective”.
This was seen in their released document – Cumulative Analysis of Post-Authorization Adverse Event Records Reports, which shows that within the first 90 days of the vaccine’s roll out under the FDA’s EUA – from December 1st. 2020 – February 28th, 2021 – there were tens of thousands of reported adverse reactions, including over 1200 deaths (source).
The report only included adverse events to the vaccine that researchers considered “serious cases,” there were thousands more submissions that were left out of this data.
The report states that in all there were a total of 42,086 case reports of individuals who had an adverse reaction to Pfizer’s vaccine worldwide, with the largest number (13,739) coming from the United States and from the UK (13,404).
As required by Congress, the FDA may only license vaccines that have been proven to be “safe and effective (Source). This alone, surely, should have been reason enough to put a stop to the administration of the product and reason to be alarmed that congress and the FDA deemed it “safe” for EUA approval.
What Are They Trying to Hide?
Yes, this has already been reported, however, it bears repeating for perspective here. If this was the information from only a fraction of data, which in itself is shocking what else is Pfizer hiding in the data?
The FDA and Pfizer are reluctant to forward more data, stating that “such records can be expected to contain both confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials.” (source)
However, they should be urgently compelled to produce the results of the clinical trials in their entirety for the safety of the public, many of which are children.
As they are reluctant to do so, as Edward Dowd says, we may assume fraud and with the already known adverse events and deaths resulting from their gene therapy jab, how can we not?
0 Comments